与Sjögren病相关的新发性耐火状态发症
Gareth Zigui Lim1, Justin Kian Guan Kwok2, Zhaoxiang Fan3
1Department of Neurology, National Neuroscience Institute, Tan Tock Seng Hospital Campus, Singapore.
BMJ neurology open
|January 21, 2026
概括
斯约格伦病 (SjD) 可以导致严重的神经问题,如脑炎和状态. 在这些罕见的病例中,早期免疫疗法对于疑似免疫媒介原因至关重要.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 斯约格伦病 (SjD) 是一种自身免疫性疾病,影响外分泌腺.
- 在SjD中,外腺体表现,包括中枢神经系统的参与,也可能发生.
- 由于症状重叠,诊断与SjD相关的神经疾病是具有挑战性的.
研究的目的:
- 报告两例急性脑炎和与Sjögren病相关的新发性耐火状态 (NORSE).
- 强调在无法解释的神经病情中考虑SjD的重要性.
- 支持怀疑免疫媒介脑炎/NORSE的早期免疫疗法.
主要方法:
- 关于两名脑炎患者和NORSE的病例报告.
- 排除传染病和其他自身免疫病因.
- 识别支持原发性肖格伦病的特征.
主要成果:
- 两位患者均出现了急性脑炎和NORSE.
- 广泛的检查排除了传染性原因和其他自身免疫性疾病.
- 随后的发现在两种情况下都支持了原发性Sjögren病.
结论:
- 系统性自身免疫性疾病,如Sjögren病,应考虑在不明原因的脑炎和NORSE.
- 当怀疑免疫媒介病理时,建议早期免疫疗法.
- 这些病例凸显了Sjögren病的神经系统表现的多样性.
相关概念视频
Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...


